Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Potent, Selective CBX2 Chromodomain Ligand and Its Cellular Activity During Prostate Cancer Neuroendocrine Differentiation
Sijie Wang, Aktan Alpsoy, Surbhi Sood, et al.
ChemBioChem (2021) Vol. 22, Iss. 13, pp. 2335-2344
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Liquid–liquid phase separation in tumor biology
Xuhui Tong, Rong Tang, Jin Xu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 135
Small-molecule discovery through DNA-encoded libraries
Alexander A. Peterson, David R. Liu
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 699-722
Closed Access | Times Cited: 91
Pharmacological targeting of the cancer epigenome
Nathaniel W. Mabe, Jennifer A. Perry, Clare F. Malone, et al.
Nature Cancer (2024) Vol. 5, Iss. 6, pp. 844-865
Closed Access | Times Cited: 19
Super-Enhancers, Phase-Separated Condensates, and 3D Genome Organization in Cancer
Seng Chuan Tang, Udhaya Vijayakumar, Ying Zhang, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2866-2866
Open Access | Times Cited: 33
Biomolecular condensates: Formation mechanisms, biological functions, and therapeutic targets
Xin Niu, Lei Zhang, Yuchen Wu, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 20
Epigenetics-Based Diagnostic and Therapeutic Strategies: Shifting the Paradigm in Prostate Cancer
Pier‐Luc Clermont
Epigenomics (2023) Vol. 15, Iss. 2, pp. 75-87
Closed Access | Times Cited: 19
SUMOylation and DeSUMOylation: Prospective therapeutic targets in cancer
Wenyan Wu, Chao Huang
Life Sciences (2023) Vol. 332, pp. 122085-122085
Closed Access | Times Cited: 13
Polycomb‐mediated gene regulation in human brain development and neurodevelopmental disorders
Nora Bölicke, Mareike Albert
Developmental Neurobiology (2022) Vol. 82, Iss. 4, pp. 345-363
Open Access | Times Cited: 19
The Epigenetic Regulatory Protein CBX2 Promotes mTORC1 Signalling and Inhibits DREAM Complex Activity to Drive Breast Cancer Cell Growth
Lucie J. Bilton, Chloe Warren, Rebecca M. Humphries, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3491-3491
Open Access | Times Cited: 19
Chemical tools targeting readers of lysine methylation
Gloria Ortiz, Tatiana G. Kutateladze, Danica Galonić Fujimori
Current Opinion in Chemical Biology (2023) Vol. 74, pp. 102286-102286
Open Access | Times Cited: 12
Chromobox proteins in cancer: Multifaceted functions and strategies for modulation (Review)
Jian Wang, Bo Yang, Xiu‐Hang Zhang, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 3
Open Access | Times Cited: 11
Chemical inhibitors targeting histone methylation readers
Xiaolei Huang, Yichang Chen, Qin Xiao, et al.
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108614-108614
Closed Access | Times Cited: 4
Epigenetic regulatory protein chromobox family regulates multiple signalling pathways and mechanisms in cancer
Weiyu Su, Weiwen Wang, Guanghui Zhang, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
Unravelling the impact of the chromobox proteins in human cancers
S. Noreen, Nicla Simonelli, Rosaria Benedetti, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Identification of substituted acetanilide compounds as small molecule CBX2 inhibitors via in silico screening
Shohei Takase, Ashutosh Kumar, Sho Yokoyama, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151882-151882
Closed Access
Covalent labeling of a chromatin reader domain using proximity-reactive cyclic peptides
Meng Yao Zhang, Hyunjun Yang, Gloria Ortiz, et al.
Chemical Science (2022) Vol. 13, Iss. 22, pp. 6599-6609
Open Access | Times Cited: 18
PRADclass: Hybrid Gleason Grade-Informed Computational Strategy Identifies Consensus Biomarker Features Predictive of Aggressive Prostate Adenocarcinoma
Alex Stanley Balraj, Sangeetha Muthamilselvan, Rachanaa Raja, et al.
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access | Times Cited: 3
Investigating the Cytosolic Delivery of Proteins by Lipid Nanoparticles Using the Chloroalkane Penetration Assay
Jing Wang, Shiying Zhang, Yamin Li, et al.
Biochemistry (2024)
Closed Access | Times Cited: 3
Recent advances in the development of peptide-based inhibitors targeting epigenetic readers of histone lysine acetylation and methylation marks
Sha Liu, Xiang Li, Xin Li, et al.
Current Opinion in Chemical Biology (2023) Vol. 75, pp. 102334-102334
Closed Access | Times Cited: 8
Novel chromobox 2 inhibitory peptide decreases tumor progression
Lindsay W. Brubaker, Donald S. Backos, Vu Nguyen, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 4-5, pp. 361-371
Closed Access | Times Cited: 7
Discovery and Optimization of WDR5 Inhibitors via Cascade Deoxyribonucleic Acid-Encoded Library Selection Approach
Shaozhao Qin, Lijian Feng, Qingyi Zhao, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1079-1092
Closed Access | Times Cited: 2
Polycomb group proteins in cancer: multifaceted functions and strategies for modulation
Sijie Wang, Sandra C. Ordonez-Rubiano, Alisha Dhiman, et al.
NAR Cancer (2021) Vol. 3, Iss. 4
Open Access | Times Cited: 15
Targeting Key Players of Neuroendocrine Differentiation in Prostate Cancer
Irene Zamora, Michael R. Freeman, Ignacio Encı́o, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13673-13673
Open Access | Times Cited: 6
Loss of CBX2 causes genomic instability and Wnt activation in high grade serous ovarian carcinoma cells
Yujia Ma, Lin Liu, Wei Zheng, et al.
Molecular Carcinogenesis (2023) Vol. 62, Iss. 4, pp. 479-492
Closed Access | Times Cited: 5
How CBX proteins regulate normal and leukemic blood cells
Anne P. de Groot, Gerald de Haan
FEBS Letters (2024) Vol. 598, Iss. 22, pp. 2788-2806
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top